Small Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 13 Oct 23 | SellCA$80,323 | Peter Rands | Individual | 470,000 | CA$0.17 | |
| 12 Oct 23 | SellCA$169,914 | Peter Rands | Individual | 945,999 | CA$0.18 | |
| 29 Sep 23 | SellCA$89,990 | Peter Rands | Individual | 611,700 | CA$0.17 | |
| 27 Sep 23 | SellCA$284,410 | Peter Rands | Individual | 1,532,001 | CA$0.19 | |
| 25 Aug 23 | SellCA$43,512 | Peter Rands | Individual | 638,000 | CA$0.068 | |
| 24 Aug 23 | SellCA$10,854 | Peter Rands | Individual | 162,000 | CA$0.067 | |
| 23 Aug 23 | SellCA$26,353 | Peter Rands | Individual | 398,000 | CA$0.067 | |
| 18 Aug 23 | SellCA$100,780 | Peter Rands | Individual | 1,520,710 | CA$0.07 |
Insider Trading Volume
Insider Buying: DMT insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 0 | 0% |
| Institutions | 2,429,096 | 0.723% |
| General Public | 333,341,041 | 99.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.3%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 2,169,096 | CA$325.4k | 8.4% | 0.05% | |||
| 260,000 | CA$39.0k | 0% | 4.42% |